North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group
Stoke-on-Trent Clinical Commissioning Group

10 Musculoskeletal and joint diseases
10-01-03 Gold

Sodium aurothiomalate Myocrisin®

Myocrisin®Sodium aurothiomalate 20mg/1ml solution for injection ampoules
Myocrisin®Sodium aurothiomalate 100mg/1ml solution for injection ampoules 



Sanofi has confirmed the discontinuation of 10mg, 20mg and 50mg ampoules of Myocrisin from 30th June 2019 (being 3 months from the shortest expiry date). There are supplies within the supply chain, and will continue until current stock is depleted.


Amber View adult BNF  View SPC online  View childrens BNF